Tumor Immunology and Immunotherapy – Cellular Methods Part B - 1st Edition - ISBN: 9780128186756

Tumor Immunology and Immunotherapy – Cellular Methods Part B, Volume 632

1st Edition

Serial Volume Editors: Lorenzo Galluzzi Nils-Petter Rudqvist
Hardcover ISBN: 9780128186756
Imprint: Academic Press
Published Date: 1st February 2020
Page Count: 412
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Quantitation of calreticulin exposure associated with immunogenic cell death
Peng Liu
2. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death
Jitka Fucikova
3. Quantitative determination of phagocytosis by bone marrow-derived dendritic cells via imaging flow cytometry
Guido Kroemer and Oliver Kepp
4. Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies
Ilio Vitale
5. Methods to assess DC-dependent priming of T cell responses by dying cells
Jitka Fucikova
6. Monitoring tumor antigen cross-presentation with human dendritic cells purified from the blood
Anne Hosmalin
7. Assessing tumor antigen cross-presentation from live tumor cells
Anne Hosmalin
8. Improved method to isolate mouse macrophages and DCs from the gut
Arthur Mortha
9. Standardized isolation of mouse and human macrophages from the blood and bone marrow
Jeffrey William Pollard
10. Methods to study tumor-associated and iPS-derived macrophages
Jeffrey William Pollard
11. In vitro assessment of cancer cell-induced polarization of macrophages
Karin E. de Visser
12. Protocol to assess the suppression of T-cell proliferation by human MDSC
Pierre van der Bruggen
13. Enzymatic and cellular assays to quantify the suppressive activity of MDSCs
Vincenzo Bronte
14. Functional Assay to Assess T-cell Inhibitory Properties of Myeloid Derived Suppressor Cells (MDSCs) Isolated from the Tumor Microenvironment of murine Glioma Models
Maria G. Castro
15. FACS Isolation and Analysis of Human Circulating and Tumor Neutrophils
Jeffrey William Pollard
16. Flow cytometry-based isolation of tumor-associated regulatory T cells and assessment of their suppressive potential
Karin E. de Visser
17. Assessment of lipid load in tumor-infiltrating Tregs by flow cytometry
Silvia Piconese
18. Preparation of single cells from tumors for single-cell RNA sequencing
Dmitriy Zamarin
19. Characterization of the tumor infiltrate by multiparametric flow cytometry and unbiased high dimensional data analysis
Romina Goldszmid
20. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF)
Jérôme Galon
21. Isolation and Characterization of Immune Cells from the Tumor Microenvironment of Genetically Engineered Pediatric High Grade Glioma Models Using the Sleeping Beauty Transposon System
Maria G. Castro
22. Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay
Udo S. Gaipl
23. Ex vivo assessment of in vivo antibody targeting to immune cells in preclinical models
Niroshana Anandasabapathy
24. Flow cytometry-based assessment of direct-targeting anti-cancer antibody immune effector functions
Olivera J. Finn
25. Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models
Laura Bracci
26. High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications
Giovanna Schiavoni
27. Generation of affinity ranged antigen-expressing tumor cell lines
Pedro Romero
28. Methods to quantify immunogenicity in tumor-derived exosomes
sheila spada


Description

Tumor Immunology and Immunotherapy – Cellular Methods Part B, Volume 632, the latest release in the Methods in Enzymology series, continues the legacy of this premier serial with quality chapters authored by leaders in the field. Topics covered include Quantitation of calreticulin exposure associated with immunogenic cell death, Side-by-side comparisons of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death, Quantitative determination of phagocytosis by bone marrow-derived dendritic cells via imaging flow cytometry, Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodies, Methods to assess DC-dependent priming of T cell responses by dying cells, and more.

Key Features

  • Contains content written by authorities in the field
  • Provides a comprehensive view on the topics covered
  • Includes a high level of detail

Readership

Experts in the field who may want to expand their technical horizons and to newcomers who need detailed introductions to basic techniques


Details

No. of pages:
412
Language:
English
Copyright:
© Academic Press 2020
Published:
1st February 2020
Imprint:
Academic Press
Hardcover ISBN:
9780128186756

Ratings and Reviews


About the Serial Volume Editors

Lorenzo Galluzzi

Lorenzo Galluzzi Serial Volume Editor

Lorenzo Galluzzi (born 1980) is currently Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College (New York, USA), and Honorary Associate Professor at the Faculty of Medicine of the Paris Descartes University (Paris, France). Prior to joining Weill Cornell Medical College (2017), Lorenzo Galluzzi was a Junior Scientist of the Research Team “Apoptosis, Cancer and Immunity” at the Cordeliers Research Center (Paris, France; 2012-2016). Lorenzo Galluzzi did his post-doctoral training at the Gustave Roussy Cancer Center (Villejuif, France; 2009-2011), after receiving his PhD from the Paris Sud University (Le Kremlin-Bicetre, France; 2005-2008). He is also Associate Director of the European Academy for Tumor Immunology (EATI), and Founding Member of the European Research Institute for Integrated Cellular Pathology (ERI-ICP). Lorenzo Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. In particular, he provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. Lorenzo Galluzzi has published more than 350 scientific articles in international peer-reviewed journals. According to a survey published by Lab Times, he is currently the 6th and the youngest of the 30 most-cited European cell biologists (relative to the period 2007–2013). Lorenzo Galluzzi currently operates as Editor-in-Chief of three journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, and Molecular and Cellular Oncology (which he co-founded in 2013). In addition, Lorenzo Galluzzi currently serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease.

Affiliations and Expertise

Weill Cornell Medical College, USA

Nils-Petter Rudqvist

Nils-Petter Rudqvist Serial Volume Editor

Nils-Petter Rudqvist received his M.Sc. (Physics, 2009) and Ph.D. (Medical Science, 2015) from the University of Gothenburg, Sweden. He decided to pursue an academic career and continue with his postdoctoral training in US. He first joined the Center for Radiological Research at Columbia University in New York where he studied gene signatures of radiation exposure. He then moved to Weill Cornell Medicine to join the program in radiation and immunity under the mentorship of Dr. Demaria. His current research is focused on investigating which neoantigens are key targets of the radiation-induced anti-tumor T cell response in mice and in patients treated with radiotherapy and immune checkpoint blockade. He recently demonstrated in a mouse model that radiation therapy diversifies the TCR repertoire of tumor infiltrating lymphocytes, an effect crucial for its synergy with immune checkpoint blockade treatment. Nils-Petter has also defined unique patters of expansion of TCR clonotypes in patients who respond or not to treatment with radiotherapy and ipilimumab. He has published 20 articles in peer-reviewed scientific journals and 60+ scientific conference abstracts.

Affiliations and Expertise

Postdoctoral Associate in Radiation Oncology, Weill Cornell Medicine, USA